Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Selenylated imidazo[1,2-a]pyridine induces cell senescence and oxidative stress in chronic myeloid leukemia cells

Version 1 : Received: 18 November 2022 / Approved: 22 November 2022 / Online: 22 November 2022 (07:49:44 CET)

A peer-reviewed article of this Preprint also exists.

Burkner, G.T.; Dias, D.A.; Souza, K.F.S.; Araújo, A.J.P.; Basilio, D.C.L.S.; Jacobsen, F.T.; Moraes, A.C.R.; Silva-Filho, S.E.; Cavalcante, M.F.O.; Moraes, C.A.O.; Saba, S.; Macedo, M.L.R.; Paredes-Gamero, E.J.; Rafique, J.; Parisotto, E.B. Selenylated Imidazo[1,2-a]pyridine Induces Cell Senescence and Oxidative Stress in Chronic Myeloid Leukemia Cells. Molecules 2023, 28, 893. Burkner, G.T.; Dias, D.A.; Souza, K.F.S.; Araújo, A.J.P.; Basilio, D.C.L.S.; Jacobsen, F.T.; Moraes, A.C.R.; Silva-Filho, S.E.; Cavalcante, M.F.O.; Moraes, C.A.O.; Saba, S.; Macedo, M.L.R.; Paredes-Gamero, E.J.; Rafique, J.; Parisotto, E.B. Selenylated Imidazo[1,2-a]pyridine Induces Cell Senescence and Oxidative Stress in Chronic Myeloid Leukemia Cells. Molecules 2023, 28, 893.

Abstract

Imidazo[1,2-a]pyridines have been studied regarding drug development. The objective of this work was to evaluate the antileukemic capacity of imidazo[1,2-a]pyridine derivatives by screening its ability as a pro-oxidant. Imidazo[1,2-a]pyridine derivatives were synthesized and oral bioavailability and toxicity were analyzed in silico. Redox screening was performed on human Kasumi, KG-1, K562 and Jurkat leukemia cells. The imidazo[1,2-a]pyridine derivative and the most responsive leukemic cell were selected for cytotoxicity, cell proliferation, cell senescence and oxidative stress assays. The predictive toxicity analysis showed a possible effect on the reproductive system, but without mutagenic, carcinogenic or irritability effects. MRK-107 against K562 cells was the compound that showed the best redox profile. MRK-107 did not induce cell death in K562 and monocyte cells. However, this compound was able to decrease cell proliferation and increase cell senescence after 48 and 72 hours. Furthermore, MRK-107 induced oxidative stress in K562 cells after 72h, increasing lipid peroxidation and decreasing reduced glutathione (GSH) contents. This study demonstrated that MRK-107-induced senescence with the involvement of oxidative stress as a possible mechanism of action, addressing this compound as a potential antitumor drug against chronic myeloid leukemia.

Keywords

Leukemia; imidazo[1,2-a]pyridines; selenide; oxidative stress; senescence; chronic myeloid leu-kemia.

Subject

Chemistry and Materials Science, Medicinal Chemistry

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.